MGMIMass Gathering Medicine

← Library

AI-DRAFTED — PHYSICIAN REVIEW IN PROGRESSThe citation for this entry was checked against Crossref and PubMed, but its summary and interpretation were drafted by an AI model from the published abstract and have not yet been individually read by a physician. Read the linked source before relying on this operationally.
Guideline ✓ verified

Preventing invasive meningococcal disease during Hajj in Saudi Arabia[1]

Al-Raddadi R, Almalki HA, Abdalal S, Amir A, Almalki S, Al-Thaqafy MS, Almudarra S, Bukhari H · 2026 · East Mediterr Health J

Summary

Multi-society expert consensus statement (four Saudi medical societies) reviewing epidemiology and immunisation policy to strengthen prevention of invasive meningococcal disease (IMD) during Hajj, where close contact among diverse pilgrims raises transmission risk. Reviewing the quadrivalent ACWY conjugate vaccine (already required for Hajj) and the serogroup B (MenB) vaccine available in Saudi Arabia, the panel recommends ADDING MenB vaccination for adults performing Hajj, specifically targeting vulnerable groups - people with chronic disease, immunocompromised individuals, those with occupational risk, children aged 2 months to 18 years, and adults >=60 years. It recommends integrating vaccination into Hajj/Umrah registration systems, with clear communication, adverse-event monitoring, and impact evaluation to support uptake.

So what

The current authoritative statement on the vaccine-preventable outbreak risk that shapes Hajj entry requirements - and the natural companion to the library's pilgrimage and surveillance material. Its planning payload is the proposed shift from ACWY-only to ACWY-plus-MenB for the vulnerable, and the delivery mechanism (bundle vaccination into the registration system, the same single-choke-point logic the pilgrimage pages favour). It names the exact vulnerable strata a mass-gathering medical planner already tracks (chronic disease, immunocompromised, the young and the >=60 elderly), tying meningococcal prevention to the dependent-populations frame. Consensus/expert-panel evidence (not primary data), so cite as recommendation and policy direction, not as an effectiveness study; entry-type guideline.

Key findings

  • Multi-society Saudi consensus on invasive meningococcal disease (IMD) prevention at Hajj
  • Recommends ADDING MenB to the existing quadrivalent ACWY conjugate requirement
  • Target vulnerable: chronic disease, immunocompromised, occupational risk, children 2mo-18yr, adults >=60
  • Delivery lever: integrate vaccination into Hajj/Umrah registration + communication + AE monitoring
  • Consensus/guideline (not primary data) — cite as policy direction; open-access WHO EMHJ

Read the paper